The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.25
Bid: 41.00
Ask: 41.50
Change: -0.50 (-1.20%)
Spread: 0.50 (1.22%)
Open: 41.75
High: 41.75
Low: 40.75
Prev. Close: 41.75
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Avacta Stock Continues Rise After Launch Of SARS-CoV-2 Test

Thu, 01st Oct 2020 06:40

Avacta Group PLC - Wetherby, England-based pre-clinical stage biotechnology company - Launches bead-assisted mass spectrometry, or BAMS, SARS-CoV-2 virus test. "The BAMS assay uses the Affimer reagents specific to the SARS-CoV-2 virus to capture the virus spike protein from the sample for rapid detection by mass spectrometry, using the installed base of these instruments in hospitals," Avacta says. Adds that one thousand samples per day can be analysed by a single technician using BAMS.

Current stock price: 155.00 pence, up 11% on Wednesday.

Year-to-date change: up sharply from 17.25p

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
22 Jul 2020 16:13

Avacta's Covid test collaboration with Adeptrix accepted into CONDOR

(Sharecast News) - Avacta Group has started work with the UK government's 'CONDOR' programme, it announced on Wednesday, to evaluate and clinically validate the high throughput Covid-19 bead-assisted mass spectrometry laboratory assay, developed with Adeptrix.

Read more
13 Jul 2020 11:23

Avacta Partners With Integumen To Detect Covid-19 In Waste Water

Avacta Partners With Integumen To Detect Covid-19 In Waste Water

Read more
13 Jul 2020 09:18

Avacta signs Covid sewage test deal with Integumen

(Sharecast News) - Biotherapeutics company Avacta Group has entered into a collaboration with its AIM peer Integumen, it announced on Monday, to evaluate recently-generated Affimer reagents that bind the SARS-CoV-2 spike protein for the detection of the coronavirus in wastewater, to provide a real-time alert system to warn of localised Covid-19 outbreaks.

Read more
24 Jun 2020 13:55

IN BRIEF: Avacta Posts Positive Results For Covid-19 Detection Test

IN BRIEF: Avacta Posts Positive Results For Covid-19 Detection Test

Read more
24 Jun 2020 08:36

Avacta upbeat on evaluation of Covid-19 test strips

(Sharecast News) - Avacta Group announced on Wednesday that the first 'Affimer'-based rapid test strips to detect SARS-CoV-2 (Covid-19) spike protein had been developed and evaluated by its partners at Cytiva - formerly GE Healthcare Life Sciences - and reportedly showed positive initial performance data.

Read more
22 Jun 2020 08:52

'No-swab' saliva test for coronavirus piloted in Britain

LONDON, June 22 (Reuters) - A weekly coronavirus testing regime using a "no-swab" saliva test is being trialled in Southampton, southern England, and could result in a simpler and quicker way to detect outbreaks of the virus, the British governme...

Read more
18 Jun 2020 11:55

Avacta reports promising findings on potential Covid therapy

(Sharecast News) - Avacta Group announced on Thursday that collaborative work with the Centre for Virus Research at the University of Glasgow has shown that its 'Affimer' reagents, which bind to the SARS-COV-2 (Covid-19) virus spike protein, prevent infection of human cells by a SARS-COV-2 model virus, and therefore provide a potential therapy for Covid-19 infection.

Read more
15 Jun 2020 15:52

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
9 Jun 2020 11:14

UK TRADING UPDATE SUMMARY: Omega Wins First Order For Antibody Test

UK TRADING UPDATE SUMMARY: Omega Wins First Order For Antibody Test

Read more
9 Jun 2020 09:30

Avacta's Covid-19 test reaches prototype stage

(Sharecast News) - Avacta said its Covid-19 antigen test had reached prototype stage and could detect the virus in model samples.

Read more
4 Jun 2020 14:31

Avacta To Raise GBP48 Million To Accelerate Development Of Therapies

Avacta To Raise GBP48 Million To Accelerate Development Of Therapies

Read more
4 Jun 2020 09:27

Avacta raising £45m to fund diagnostics and therapies pipeline

(Sharecast News) - Biotherapeutic and reagent developer Avacta Group announced its intention to raise up to £45m through a placing to institutional and other investors, a direct subscription with the company, and offers to retail and other investors via the PrimaryBid platform, it announced on Thursday.

Read more
20 May 2020 10:16

Avacta signs Covid-19 test distribution deal with Boohoo founders

(Sharecast News) - Avacta Group has entered into an exclusive distribution agreement with Medusa19 for direct-to-consumer sales of a saliva-based rapid test for the Covid-19 antigen, it announced on Wednesday.

Read more
11 May 2020 12:03

UK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations

UK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations

Read more
11 May 2020 08:43

Avacta Group ships Covid-19 testing reagents

(Sharecast News) - Biotherapeutics developer Avacta Group shipped out reagents for Covid-19 antigen testing to its diagnostic test development partners on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.